Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019
- 12 May 2019
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 76 (2), 142-150
- https://doi.org/10.1016/j.eururo.2019.04.033
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Early Detection of Prostate Cancer: AUA GuidelineJournal of Urology, 2013
- Quality-of-Life Effects of Prostate-Specific Antigen ScreeningNew England Journal of Medicine, 2012
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2012
- Individualized Estimation of the Benefit of Radical Prostatectomy from the Scandinavian Prostate Cancer Group Randomized TrialEuropean Urology, 2012
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-upJNCI Journal of the National Cancer Institute, 2012
- Cancer-Specific and Other-Cause Mortality After Radical Prostatectomy Versus Observation in Patients with Prostate Cancer: Competing-Risks Analysis of a Large North American Population-Based CohortEuropean Urology, 2011
- Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50Cancer, 2010
- Long-Term Prediction of Prostate Cancer Up to 25 Years Before Diagnosis of Prostate Cancer Using Prostate Kallikreins Measured at Age 44 to 50 YearsJournal of Clinical Oncology, 2007
- Life expectancy and the value of early detectionJournal of Health Economics, 2005
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004